Clinical studies recruiting near Shijiazhuang

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Hebei Provincial Hospital of Traditional Chinese Medicine · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Bre
Phase 2 · The Fourth Hospital of Hebei Medical University · Hebei Medical University Fourth Hospital · NCT04159142 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Local Institution - 0185 · Bristol-Myers Squibb · NCT06929273 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The Second Hospital of Hebei Medical Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Phase 1/Phase 2 · The First Hospital of Hebei Medical University · Chipscreen Biosciences, Ltd. · NCT07129382 A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · The Second Hospital of Hebei Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · The Fourth Hospital of Hebei Medical University · Shanghai Henlius Biotech · NCT07160335 The Chinese Familial Alzheimer's Network
Phase N/A · First Hospital of Shijiazhuang City · Capital Medical University · NCT03657732 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · The Second Hospital of Hebei Medical University · Amgen · NCT07037433 A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Phase 3 · Shijiazhuang People's Hospital · Hasten Biopharmaceutical Co., Ltd. · NCT06568471 Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）
Phase 2 · the Fourth Hospital of Hebei Medical University · Hebei Medical University Fourth Hospital · NCT06949111 Robot-Assisted vs Manual Transradial Cerebral Angiography
NA · The First Hospital of Hebei Medical University · The First Hospital of Hebei Medical University · NCT07696936 Clinical Trials of Quadrivalent Influenza Vaccine
Phase 1/Phase 2 · Hebei Province Centers for Disease Control and Prevention · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · NCT06824519 A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
Phase 3 · The First Hospital of Hebei Medical University · Tasly Pharmaceutical Group Co., Ltd · NCT06000956 A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectabl
Phase 2 · Fourth Hospital of Hebei Medical University · Innovent Biologics (Suzhou) Co. Ltd. · NCT06797297 Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens
Phase N/A · The 980th Hospital of the People's Liberation Army Joint Log · Huashan Hospital · NCT07694648 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0254 · Celgene · NCT05519085 A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
Phase 1/Phase 2 · The Fourth Hospital of Hebei Medical University · Jiangsu HengRui Medicine Co., Ltd. · NCT06015048 A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
Phase 1/Phase 2 · Research site017 · Allist Pharmaceuticals, Inc. · NCT05276726 Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · Research Site · AstraZeneca · NCT06465810 Trilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors
Phase 1 · The Fourth Hospital of Hebei Medical University · Hebei Medical University Fourth Hospital · NCT07490236 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · The Second Hospital of Hebei Medical University - Main · Biogen · NCT06962800 Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
Phase 3 · Shijiazhuang People's Hospital · Beletalent (Zhuhai) Pharmaceutical Co., Ltd · NCT06817265 A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-pos
Phase 1/Phase 2 · The Fourth Hospital of Hebei Medical University · Antengene Biologics Limited · NCT07327229 Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NA · Hebei Medical University Third Hospital · Peking Union Medical College Hospital · NCT05866029 The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management
NA · Research Site · AstraZeneca · NCT06909773 A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants Wit
Phase 1 · The Fourth Hospital of Hebei Medical University · BeOne Medicines · NCT06427941 A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome
Phase 3 · Hebei Provincial Hospital of Traditional Chinese Medicine · Tasly Pharmaceutical Group Co., Ltd · NCT06696261 REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry
Phase 4 · The Fourth Hospital of Hebei Medical University · Nanfang Hospital, Southern Medical University · NCT05728775 Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Phase 2 · The Second Hospital of HeBei Medical University · InSilico Medicine Hong Kong Limited · NCT07265570

Look up another city

Look up another condition